ChemicalBook--->CAS DataBase List--->67763-87-5

67763-87-5

67763-87-5 Structure

67763-87-5 Structure
IdentificationBack Directory
[Name]

Bleomycin hydrochloride
[CAS]

67763-87-5
[Synonyms]

BleomycinHCl
bleomycinchlorhydrate
BLEOMYCIN HYDROCHLORIDE
BLEOMYCIN HYDROCHLORIDES
BleomycinA5/Pingyangmycin
BleoMycin A4A5 Hydrochloride
Bleomycin hydrochloride USP/EP/BP
[Molecular Formula]

C50H71N16O21S2R.x(HCl)
[MDL Number]

MFCD00211692
Chemical PropertiesBack Directory
[storage temp. ]

4°C, protect from light
[solubility ]

DMSO: 125 mg/mL (86.15 mM)
[form ]

Solid
[color ]

White to light yellow
Safety DataBack Directory
[Symbol(GHS) ]

Health Hazard (GHS08)
GHS08
[Signal word ]

Warning
[Hazard statements ]

H351
[Precautionary statements ]

P201-P202-P281-P308+P313-P405-P501
Hazard InformationBack Directory
[Originator]

Bleomycin Hydrochloride,Nippon Kayaku, Co.,Japan
[Uses]

Bleomycin hydrochloride is a DNA synthesis inhibitor. Bleomycin hydrochloride is a DNA damaging agent. Bleomycin hydrochloride is an antitumor antibiotic[1].
[Manufacturing Process]

To a medium having a composition of 6.4 % of millet jelly, 0.5 % of glucose, 3.5 % of soybean powder, 0.75 % of corn steep liquor, 0.3 % of sodium chloride, 0.1 % of potassium secondary phosphate, 0.05 % of zinc sulfate, 0.01 % of copper sulfate, 0.2 % of sodium nitrate and 0.01 % of Toho No. 1 (trade name for a surface active agent composed of polyoxyethylene manufactured by Toho Chemical Industry Co. Ltd., Japan) was added 3-aminopropyl- dimethylsulfonium bromide hydrobromate in a proportion of 0.4 mg/ml to adjust the pH of the medium to 6.5.
Each 100 ml of the thus treated medium was separately charged into a Sakaguchi flask and was then sterilized. Subsequently, Streptomyces verticillus (ATCC No. 15003) was inoculated in the medium and was cultured at 27°C for 8 days with stirring at 130 r.p.m. Thereafter, the culture liquors (4.5 L) were collected and filtered to obtain 3.0 L of a filtrate (potency 38.8 mg/ml, total potency 416.4 mg). This culture filtrate was passed through and adsorbed on a column packed with 200 ml of Amberlite IRC-50 and was washed with water and was eluted with 0.5 N hydrochloric acid. 1.0 L of the eluate was neutralized, was passed through and adsorbed on a column packed with 100 ml of active carbon, was washed and was then eluted by use of a 1:1 (by volume) mixture of acetone - 0.02 N aqueous hydrochloric acid solution, and fractions active to Mycobacterium 607 were collected and concentrated to dryness. The resulting residue was dissolved in 5 ml of an 80 % aqueous methanol solution and was charged into a column packed with 30 ml of neutral alumina, followed by elution with an 80 % aqueous methanol solution. Subsequently, bleomycin-containing fractions were collected and concentrated to dryness to obtain 195 mg of bleomycin hydrochloride (potency 650.7 mcg/mg, total potency 172 mg). The yield from the culture filtrate was 30.5 %.
[Therapeutic Function]

Antibiotic
[in vivo]

Bleomycin hydrochloride ((Bleomycin hydrochloride and Bleomycin sulfate are equivalent)) can be used to create animal models of pulmonary fibrosis. Intratracheal administration of Bleomycin sulfate (3.5-4.0 mg/kg) on day 0 elicits a treatment response, characterized by a decrease in body weight of the subjects on day 4, followed by recovery and continued growth until the end of the experiment. This treatment also significantly increases the levels of hydroxyproline in lung tissue and the mass of the right caudal lobe of the lung. In 8-week-old male BALB/c mice (weighing approximately 20-30 grams), intratracheal instillation of Bleomycin sulfate at a dose of 5.0 mg/kg/day induces pulmonary fibrosis and promotes the expression of α-SMA and type I collagen. Similarly, in 8-week-old male C57BL/6 mice (average weight around 24.5 grams), intratracheal injection of 2.5 mg/kg Bleomycin sulfate effectively induces pulmonary fibrosis. Bleomycin sulfate is rapidly absorbed after administration via intramuscular, subcutaneous, intraperitoneal, or intrapleural routes, reaching peak plasma concentrations within approximately 60 minutes. When given intravenously, less than 1% of the drug binds to plasma proteins, ensuring high bioavailability. The mean plasma clearance rate of Bleomycin sulfate is about 70 mL/min/m2, indicating high plasma elimination and urinary excretion rates[3][4][5][6].

Induction of Pulmonary Fibrosis[7]
Background
Bleomycin sulfate can lead to lung patchy parenchymal inflammation, epithelial cell injury with reactive hyperplasia, epithelial-mesenchymal transition, activation and differentiation of fibroblasts to myofibroblasts, and basement membrane and alveolar epithelium injures. The experimental use of Bleomycin sulfate is to induce pulmonary fibrosis animal models.
Specific Modeling Methods
Mice: C57BL/6 12-week-old
Administration: 3-5 mg/kg intratracheal administration sprays on day one
Note
The mice were housed in separate stainless-steel cages (six mice per cage) in a temperature-controlled environment (20-24°C) on 12 h light-dark cycles with unrestricted access to food and water.
Modeling Indicators
Body quality changes: The appetite activity is reduced, with the fur less shiny, the spirits being lethargic, and the bodyweight decreasing. Showed shortness of breath, coughing, and noisy.
Lung changes: Increased fibrotic consolidations, non-aerated lung area, and high-density lung area. Pulmonary function decreased.
Molecular changes: Increased indicators: TGF-β1, TNF-α, IL-6, and GM-CSF in bronchoalveolar lavage fluid.
Correlated Product(s): Bleomycin hydrochloride (HY-17565A)
Opposite Product(s): Neotuberostemonine (HY-N3196)

Animal Model:Male Fischer 344 rats, 8-10 week old, weighing 150-250g[3]
Dosage:3.5-4 mg/kg
Administration:Intra-tracheal
Result:Body weights decreased by day 4 then increased by Day 7 through the end of the study.
[References]

[1] Hovhannisyan G, et al. Comparative analysis of individual chromosome involvement in micronuclei induced by bleomycin in human leukocytes. Mol Cytogenet. 2016 Jun 21;9:49. DOI:10.1186/s13039-016-0258-4
[2] Jaaskela-Saari HA, et al. Squamous cell cancer cell lines: sensitivity to bleomycin and suitability for animal xenograft studies. Acta Otolaryngol Suppl. 1997;529:241-4. DOI:10.3109/00016489709124133
[3] Corboz MR, et al. Therapeutic administration of inhaled INS1009, a LRX-15 prodrug formulation, inhibits bleomycin-induced pulmonary fibrosis in rats. Pulm Pharmacol Ther. 2018 Apr;49:95-103. DOI:10.1016/j.pupt.2018.01.012
[4] Kang Miao, et al. Scutellarein inhibits BLM-mediated pulmonary fibrosis by affecting fibroblast differentiation, proliferation, and apoptosis. Ther Adv Chronic Dis. 2020 Jul 30;11:2040622320940185. DOI:10.1177/2040622320940185
[5] Ling Peng, et al. Scutellarin ameliorates pulmonary fibrosis through inhibiting NF-κB/NLRP3-mediated epithelial-mesenchymal transition and inflammation. Cell Death Dis. 2020 Nov 13;11(11):978. DOI:10.1038/s41419-020-03178-2
Spectrum DetailBack Directory
[Spectrum Detail]

Bleomycin hydrochloride(67763-87-5)1HNMR
67763-87-5 suppliers list
Company Name: Zhejiang Hisun Pharmaceutical Co., Ltd.  Gold
Telephone: 0576-88827984
Website: www.hisunpharm.com
Company Name: Shanghai Aladdin Bio-Chem Technology Co.,LTD  
Telephone: 400-6206333 13167063860
Website: www.aladdin-e.com/
Company Name: Shanghai Witofly Chemical Co.,Ltd  
Telephone:
Website: www.witofly.com
Company Name: ShangHai Caerulum Pharma Discovery Co., Ltd.  
Telephone: 18149758185 18149758185
Website: www.caerulumpharma.com
Company Name: Bide Pharmatech Ltd.  
Telephone: 400-164-7117 18317119277
Website: www.bidepharm.com
Company Name: Shanghai Macklin Biochemical Co.,Ltd.  
Telephone: 15221275939 15221275939
Website: www.macklin.cn
Company Name: Credit Asia Chemical Co., Ltd.  
Telephone: +86 (21) 61124340
Website: www.chemicalbook.com/ShowSupplierProductsList16523/0_EN.htm
Company Name: Shanghai Lollane Biological Technology Co.,Ltd.  
Telephone: 021-52996696,15000506266 15000506266
Website: http://www.bioll.com
Company Name: Shanghai YuanYe Biotechnology Co., Ltd.  
Telephone: 18916372613
Website: www.shyuanye.com
Company Name: Shanghai Rechem science Co., Ltd.  
Telephone: 021-31433387 15618786686
Website: http://cn.rechemscience.com
Company Name: Rhawn Reagent  
Telephone: 400-400-1332688 18019345275
Website: http://www.rhawn.cn
Company Name: Twochem Co.Ltd.  
Telephone: 021-58111628 15800915896
Website: cn.twochem.com
Company Name: Nanjing crow LuNing pharmaceutical technology co., LTD  
Telephone: 13382066392
Website: www.chemicalbook.com/ShowSupplierProductsList30681/0_EN.htm
Company Name: Shanghai Jizhi Biochemical Technology Co. Ltd.  
Telephone: 021-4009004166/18616739031 18616739031
Website: www.acmec-e.com/
Company Name: Shanghai Hongye Biotechnology Co. Ltd  
Telephone: 400-9205774 400-920-5774
Website: www.glpbio.cn
Company Name: Dideu Industries Group Limited  
Telephone: +86-29-81148696 +86-15129568250
Website: www.dideu.com
Company Name: Baoji Guokang Healthchem co.,ltd  
Telephone: +8615604608665 15604608665
Website: www.gk-bio.com
Company Name: Xi'an ZB Biotech Co.,Ltd  
Telephone:
Website: www.xazbbio.cn
Tags:67763-87-5 Related Product Information
9041-93-4 13392-28-4 5470-11-1 119413-54-6 22204-88-2 84485-00-7 7188-38-7 2999-46-4 2769-64-4 36635-61-7 645-96-5 14542-93-9 39687-95-1